Company profileNutraceutical & supplements#771 of 1,318 in Pakistan✓ No DRAP alerts

OPTIMUS

Nutraceutical & supplement manufacturer · 11 registered products

Ranked #10 of 20 companies in Decongestants And Antiallergics

11 registered products 10 distinct molecules 0 DRAP alerts

11 of this company's registrations sit in the DRAP category “Eye”, which is registered as a category rather than by molecule — so a low molecule count reflects how supplements are registered, not a small portfolio. Nutraceutical manufacturers advertise direct to consumers and are among the largest marketing spenders in the Pakistani market.

Company overview

registered products

distinct molecules

therapeutic classes

DRAP alerts

OPTIMUS is a nutraceutical and dietary-supplement manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 11 product registrations. Its portfolio is concentrated in Decongestants And Antiallergics and Antiglaucoma Preparations And Miotics. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by OPTIMUS

3 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Other Ophthalmologicals, Lubricant 2

POLYGEL10 GRs 237.5 PolygelRs 237.5

Eye Conditions 1

PolytearsRs 230

Top molecules by brand count

Eye8 brands

Tobramycin3 brands

Timolol2 brands

Dexamethasone1 brand

Polyacrylic Acid1 brand

Dorzolamide1 brand

Ketorolac Tromethamine1 brand

Loteprednol Etabonate1 brand

Nepafenac1 brand

Olopatadine1 brand

Therapeutic classes

Price band (DRAP official ceilings)

Registered products priced by source

DVAGO1 products · Rs 237.5 – Rs 237.5

Median across source: Rs 237.5

Regulatory record

✓

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

INNVOTEK PHARMACEUTICALS9 shared molecules

VEGA PHARMACEUTICALS LTD.9 shared molecules

HELIX PHARMA (PRIVATE) LIMITED8 shared molecules

Schazoo Laboratories (Pvt) Ltd8 shared molecules

ALZA Pharma8 shared molecules

Genix Pharma Private Limited7 shared molecules

Atco Pharma International (Pvt) Ltd7 shared molecules

RAY PHARMA7 shared molecules

REMINGTON PHARMACEUTICAL INDUSTRIES (PVT) LTD.7 shared molecules

Medipak (Pvt) Ltd7 shared molecules

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

INNVOTEK PHARMACEUTICALS holds 43 molecules not in this portfolio

VEGA PHARMACEUTICALS LTD. holds 4 molecules not in this portfolio

HELIX PHARMA (PRIVATE) LIMITED holds 113 molecules not in this portfolio

Get the full profile for OPTIMUS

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included